Bayer AG BAYRY announced that it will acquire rights to the late-stage specialty cardiovascular biopharmaceutical company ...

Berenberg Bank analyst Sebastian Bray maintained a Hold rating on Bayer (BAYRY – Research Report) yesterday and set a price target of $5.80.

Bayer AG (BAYRY) reports strong performance in Pharmaceuticals and Consumer Health, while facing headwinds in Crop Science ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Bayer (OTCPK:BAYZF) shares fell ~11% in European trading on Tuesday after the German conglomerate, with its Q3 financials, ...

Bayer on Tuesday struck a collaboration deal with U.S. biotech firm Cytokinetics to acquire certain rights in Japan to an ...

In a crisis, psychologists recommend focusing on factors within our control. Bayer’s chief executive Bill Anderson has duly been focusing on self-help measures such as efficiencies and cost cuts as he ...

Q3 2024 Earnings Conference Call November 12, 2024 8:00 AM ETCompany ParticipantsBill Anderson - Chairman & CEOWolfgang Nickl ...

Bayer AG’s stock slumped on Tuesday as the German giant issued a profit warning on agricultural demand. Germany-listed shares of Bayer XE:BAYN dropped 11% as the company said the agricultural ...

Bayer share price crashed to its lowest level in over twenty years as concerns about its future continued. It plunged to a ...